Drug Shortage Report for ETOPOSIDE INJECTION

Last updated on 2020-03-16 History
Report ID 68626
Drug Identification Number 02080036
Brand name ETOPOSIDE INJECTION
Common or Proper name ETOPOSIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ETOPOSIDE
Strength(s) 20MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10ML
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-04
Estimated end date 2020-03-31
Actual end date 2020-03-15
Shortage status Resolved
Updated date 2020-03-16
Company comments Out of stock
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-12-04 English Compare
v2 2018-12-04 French Compare
v3 2018-12-05 English Compare
v4 2018-12-12 English Compare
v5 2018-12-12 French Compare
v6 2019-04-11 English Compare
v7 2019-04-11 French Compare
v8 2019-06-13 English Compare
v9 2019-06-13 French Compare
v10 2019-06-27 English Compare
v11 2019-06-27 French Compare
v12 2019-07-31 English Compare
v13 2019-07-31 French Compare
v14 2019-08-29 English Compare
v15 2019-08-29 French Compare
v16 2019-09-19 English Compare
v17 2019-09-19 French Compare
v18 2019-10-17 English Compare
v19 2019-10-17 French Compare
v20 2019-10-24 English Compare

Showing 1 to 20 of 25